KPV alternatives.
8 compounds compared to KPV, ranked by published evidence tier and regulatory status, not by what's marketed hardest.
KPV is a deliberate piece of design: the smallest fragment of alpha-MSH, residues 11 to 13, that keeps the parent hormone's anti-inflammatory activity while dropping its pigment-producing action. That trade is usually why people chose it, so alternatives searches here tend to be about evidence and legality rather than about the mechanism. KPV is not approved by the FDA or other major regulators, has no marketed drug product, and is not a recognized dietary supplement ingredient, so any human use sits outside regulatory approval. Within the melanocortin family the compounds with actual approvals, afamelanotide and bremelanotide, were developed for entirely different purposes and are not anti-inflammatory substitutes.
KPV is a synthetic tripeptide composed of L-lysine, L-proline, and L-valine (Lys-Pro-Val), corresponding to the C-terminal residues 11-13 of alpha-melanocyte-stimulating hormone (alpha-MSH).
- 01AfamelanotideA tierFDA-approvedMelanotan I · Scenesse
Acts through the melanocortin receptor activation pathway, like KPV. FDA-approved.
- 02PT-141B tierFDA-approvedbremelanotide · Vyleesi
Acts through the melanocortin receptor activation pathway, like KPV. FDA-approved.
- 03Thymosin α-1C tierIn human trialsZadaxin
Acts through the immune and inflammatory modulation pathway, like KPV. In human trials.
- 04VIPC tierResearch / preclinicalvasoactive intestinal peptide
Acts through the immune and inflammatory modulation pathway, like KPV. Research / preclinical.
- 05Thymosin β-4D tierResearch / preclinical
Acts through the immune and inflammatory modulation pathway, like KPV. Research / preclinical.
- 06Melanotan IID tierResearch / preclinical
Acts through the melanocortin receptor activation pathway, like KPV. Research / preclinical.
- 07ThymalinD tierResearch / preclinicalthymus peptide extract
Same category: immune & inflammation. Research / preclinical.
- 08LL-37F tierResearch / preclinical
Same category: immune & inflammation. Research / preclinical.
An “alternative” here means a compound that shares KPV's mechanism pathway or sits in the same category, not a marketing substitute. Each is ordered by PepCue's evidence tier (a weighted 0–100 score across human data, safety, replication and regulatory clarity), then by whether it's actually approved. This is a research reference, not medical or purchasing advice: an alternative sitting higher on evidence does not mean it's right, safe, or legal for any given use. Reviewed June 1, 2026.
PepCue keeps every compound, dose and lab in one private, provider-ready timeline, whichever one you land on.